# ASC618 Gene Therapy in Hemophilia A Patients

> **NCT04676048** · PHASE1,PHASE2 · RECRUITING · sponsor: **ASC Therapeutics** · enrollment: 12 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** ASC618

## Key facts

- **NCT ID:** NCT04676048
- **Lead sponsor:** ASC Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-03
- **Primary completion:** 2023-12
- **Final completion:** 2026-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04676048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04676048, "ASC618 Gene Therapy in Hemophilia A Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04676048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*